Table 1. Clinicopathological features of lung SQC and AC.
Number of subjects (%)
|
|||
---|---|---|---|
SQC | AC | P-value* | |
Total | 37 (100) | 32 (100) | |
Gender | 0.007 | ||
Male | 32 (86) | 18 (56) | |
Female | 5 (14) | 14 (44) | |
Age (years) | 0.415 | ||
−64 | 12 (32) | 15 (47) | |
65− | 20 (54) | 15 (47) | |
75+ | 5 (14) | 2 (6) | |
Smoking | 0.013 | ||
Non smoker | 2 (5) | 10 (31) | |
Smoker | 29 (78) | 20 (63) | |
Unknown | 6 (16) | 2 (6) | |
Tumour differentiation | 0.441 | ||
Well | 8 (22) | 7 (22) | |
Moderate | 23 (62) | 16 (50) | |
Poor | 6 (16) | 9 (28) | |
P16 a | 0.799 | ||
Negative (−9%) | 11 (31) | 11 (34) | |
Positive (10%−) | 25 (69) | 21 (66) | |
P53 a | 0.809 | ||
Negative (−9%) | 20 (56) | 19 (59) | |
Positive (10%−) | 16 (44) | 13 (41) |
SQC= squamous cell carcinoma; AC=adenocarcinoma.
*P-values for difference between SQCs and ACs were obtained from Fisher's exact test.
Expression of p16 and p53 was not examined in one SQC because of the shortage of tissue sample.